BioMarin Pharmaceutical Inc. (BMRN) vs Bio-Techne Corporation (TECH)
A side-by-side comparison of BioMarin Pharmaceutical Inc. and Bio-Techne Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMRN
BioMarin Pharmaceutical Inc.
$56.09HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
TECH
Bio-Techne Corporation
$72.46HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
Total return — BMRN vs TECH
growth of $100 · dividends reinvested · last 10yBMRN -39.5% (-4.9%/yr)TECH +177.7% (+10.8%/yr)TECH compounded faster over this window
BMRN TECH
BMRN vs TECH: by the numbers
- •TECH is the larger company ($11.34B vs $10.84B market cap).
- •TECH trades at the lower trailing earnings multiple (62.46 vs 143.82 P/E), one valuation lens rather than an overall verdict.
- •TECH converts more revenue to profit (14.97% vs 2.14% net margin).
- •BMRN grew revenue faster over the past five years (12.19% vs 5.47% CAGR).
- •TECH pays a dividend (0.55% yield), while BMRN has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BMRN | TECH |
|---|---|---|
| P/E ratio | 143.82 | 62.46 |
| Forward P/E | N/A | 35.42 |
| PEG ratio | N/A | 10.55 |
| P/S ratio | 3.18 | 9.34 |
| P/B ratio | 1.71 | 5.38 |
| EV / EBITDA | 33.24 | 32.55 |
| FCF yield | 6.76% | 2.32% |
Profitability
| Metric | BMRN | TECH |
|---|---|---|
| Gross margin | 75.55% | 65.77% |
| Operating margin | 16.56% | 20.73% |
| Net margin | 2.14% | 14.97% |
| ROE | 1.15% | 8.63% |
| ROIC | 1.40% | 7.86% |
Dividends
| Metric | BMRN | TECH |
|---|---|---|
| Dividend yield | N/A | 0.55% |
| Payout ratio | N/A | 34.48% |
Growth (annualized)
| Metric | BMRN | TECH |
|---|---|---|
| Revenue CAGR (5Y) | 12.19% | 5.47% |
| EPS CAGR (5Y) | -17.46% | 5.16% |
| FCF CAGR (5Y) | 33.84% | -3.08% |
| Total return CAGR (5Y) | -5.59% | -9.26% |
Frequently asked
- Which has the lower trailing P/E, BMRN or TECH?
- TECH has the lower trailing P/E: BMRN trades at 143.82 and TECH at 62.46. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BMRN or TECH?
- Over the past five years, BMRN grew revenue faster — BMRN at a 12.19% CAGR versus TECH at 5.47%.
- Does BMRN or TECH pay a bigger dividend?
- TECH pays a dividend (0.55% yield), while BMRN has no payments in the available dividend history.
- Is BMRN or TECH more profitable?
- TECH runs the higher net margin — BMRN at 2.14% versus TECH at 14.97%.
- How have BMRN and TECH total returns compared?
- Over the past 10 years, BMRN delivered -4.98% and TECH delivered 10.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioMarin Pharmaceutical P/E ratioBio-Techne P/E ratioBio-Techne dividend yieldBioMarin Pharmaceutical ROEBio-Techne ROEBioMarin Pharmaceutical operating marginBio-Techne operating marginBioMarin Pharmaceutical revenue growthBio-Techne revenue growthBioMarin Pharmaceutical free cash flowBio-Techne free cash flow
BioMarin Pharmaceutical & Bio-Techne appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.